BG64165B1 - Дозирана лекарствена форма на ибупрофен - Google Patents

Дозирана лекарствена форма на ибупрофен Download PDF

Info

Publication number
BG64165B1
BG64165B1 BG102744A BG10274498A BG64165B1 BG 64165 B1 BG64165 B1 BG 64165B1 BG 102744 A BG102744 A BG 102744A BG 10274498 A BG10274498 A BG 10274498A BG 64165 B1 BG64165 B1 BG 64165B1
Authority
BG
Bulgaria
Prior art keywords
dosage form
ibuprofen
weight
bicarbonate
sodium
Prior art date
Application number
BG102744A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102744A (en
Inventor
Ian A. Price
Original Assignee
The Boots Company P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company P.L.C. filed Critical The Boots Company P.L.C.
Publication of BG102744A publication Critical patent/BG102744A/xx
Publication of BG64165B1 publication Critical patent/BG64165B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG102744A 1996-02-21 1998-09-02 Дозирана лекарствена форма на ибупрофен BG64165B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition
PCT/EP1997/000841 WO1997030699A2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Publications (2)

Publication Number Publication Date
BG102744A BG102744A (en) 1999-05-31
BG64165B1 true BG64165B1 (bg) 2004-03-31

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102744A BG64165B1 (bg) 1996-02-21 1998-09-02 Дозирана лекарствена форма на ибупрофен

Country Status (25)

Country Link
US (1) US20020034540A1 (ja)
EP (1) EP0881899B1 (ja)
JP (2) JP2000507922A (ja)
KR (1) KR19990087084A (ja)
CN (1) CN1215989A (ja)
AT (1) ATE273696T1 (ja)
AU (1) AU722991B2 (ja)
BG (1) BG64165B1 (ja)
CA (1) CA2246344C (ja)
CZ (1) CZ298371B6 (ja)
DE (1) DE69730314T2 (ja)
DK (1) DK0881899T3 (ja)
ES (1) ES2227670T3 (ja)
GB (1) GB9603699D0 (ja)
HU (1) HUP9901454A3 (ja)
IL (1) IL125803A0 (ja)
NO (1) NO983825L (ja)
NZ (1) NZ331416A (ja)
PL (1) PL187383B1 (ja)
PT (1) PT881899E (ja)
RU (1) RU2182000C2 (ja)
SK (1) SK285032B6 (ja)
UA (1) UA55407C2 (ja)
WO (1) WO1997030699A2 (ja)
ZA (1) ZA971446B (ja)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
AU2002258013A1 (en) * 2001-04-10 2002-10-28 Fakhreddin Jamali Animal model for evaluating analgesics
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
CA2510319A1 (en) * 2002-12-20 2004-07-15 Thomas J. Smith High pressure compaction for pharmaceutical formulations
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
AU2005247048B2 (en) * 2004-05-28 2007-12-13 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EA014443B1 (ru) * 2004-06-29 2010-12-30 Никомед Данмарк Апс Фармацевтическая композиция (варианты) и способ ее производства
JP2008509207A (ja) * 2004-08-12 2008-03-27 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 溶融押出しにより作製するパラセタモール、ｎｓａｉｄ及び糖アルコールを含む顆粒
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
ZA200702694B (en) * 2004-09-30 2008-07-30 Scolr Pharma Inc Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CA2589079A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
WO2006084793A2 (de) * 2005-02-09 2006-08-17 Boehringer Ingelheim International Gmbh Filmtabletten enthaltend ibuprofen-lysinat
AU2006226293B2 (en) 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
EP1926481A2 (en) * 2005-09-19 2008-06-04 Albermarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20070521L (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US7867515B2 (en) * 2006-12-20 2011-01-11 TEVA Woman's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
CA2723409C (en) * 2008-05-09 2016-11-08 Atacama Labs Oy Method and apparatus for dry granulation
BRPI0916344A2 (pt) * 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2010270976B2 (en) * 2009-06-22 2014-03-20 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
JP2017519015A (ja) 2014-07-02 2017-07-13 オブセヴァ エス．エー． Ｏｔ−ｒ活性に関する疾患を治療するための方法に有用な結晶質の（３ｚ，５ｓ）−５−（ヒドロキシメチル）−１−［（２’−メチル−１，１’−ビフェニル−４−イル）カルボニル］ピロリジン−３−オン о−メチルオキシム
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
DE69231359T2 (de) * 1991-05-13 2001-02-08 The Boots Co., Plc Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
ATE180668T1 (de) * 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel

Also Published As

Publication number Publication date
ZA971446B (en) 1997-11-25
WO1997030699A2 (en) 1997-08-28
DK0881899T3 (da) 2004-12-20
EP0881899B1 (en) 2004-08-18
CA2246344C (en) 2009-01-20
DE69730314T2 (de) 2005-08-18
SK114298A3 (en) 1999-01-11
PL187383B1 (pl) 2004-06-30
JP2009073847A (ja) 2009-04-09
UA55407C2 (uk) 2003-04-15
EP0881899A2 (en) 1998-12-09
DE69730314D1 (de) 2004-09-23
NO983825L (no) 1998-10-20
RU2182000C2 (ru) 2002-05-10
HUP9901454A3 (en) 2001-04-28
CZ298371B6 (cs) 2007-09-12
PL328465A1 (en) 1999-02-01
CZ261798A3 (cs) 1998-11-11
CN1215989A (zh) 1999-05-05
NO983825D0 (no) 1998-08-20
KR19990087084A (ko) 1999-12-15
JP2000507922A (ja) 2000-06-27
PT881899E (pt) 2004-12-31
HUP9901454A2 (hu) 1999-08-30
WO1997030699A3 (en) 1997-10-09
AU722991B2 (en) 2000-08-17
NZ331416A (en) 2000-02-28
ES2227670T3 (es) 2005-04-01
CA2246344A1 (en) 1997-08-28
SK285032B6 (sk) 2006-05-04
GB9603699D0 (en) 1996-04-17
ATE273696T1 (de) 2004-09-15
AU1793797A (en) 1997-09-10
BG102744A (en) 1999-05-31
IL125803A0 (en) 1999-04-11
US20020034540A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
RU2182000C2 (ru) Дозированная форма ибупрофена
JP2009073847A6 (ja) イブプロフェンの剤型
JP5752227B2 (ja) 口腔内崩壊錠
US9492541B2 (en) Phenylepherine containing dosage form
US20030008003A1 (en) Compositions for enhanced absorption of NSAIDs
US20050266032A1 (en) Dosage form containing multiple drugs
WO2006022996A2 (en) Dosage form containing multiple drugs
NZ539749A (en) Immediate release tablets of thrombin inhibitors i.e. melagatran and inogatran comprsing strach and cellulose as fillers
BRPI0613611A2 (pt) formulações de alta concentração de fármaco e formas de dosagens
EP0749308B1 (en) Film coated tablet of paracetamol and domperidone
US20050249808A1 (en) NSAIDs compositions containing tartaric acid
KR101896700B1 (ko) 정제
JP5663238B2 (ja) 内服固形製剤及びその製造方法
WO2006056042A1 (en) Nsaid compositions exhibiting clinical superiority
JP2012046454A (ja) 内服用錠剤およびその製造方法
EP0975337B1 (en) Fast release compressed tablet of flurbiprofen
MXPA98006688A (en) Dosage form of ibuprophene
JP2002128670A (ja) 錠剤用医薬組成物
MX2008000963A (en) High drug load formulations and dosage forms